Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark; Copenhagen Research Group for Inflammatory Skin (CORGIS), Herlev and Gentofte Hospital, Hellerup, Denmark.
Department of Dermatology and Allergy, University Hospital Bonn, Bonn, Germany; Christine Kühne-Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.
Ann Allergy Asthma Immunol. 2021 Jul;127(1):49-56.e1. doi: 10.1016/j.anai.2021.02.026. Epub 2021 Mar 5.
Atopic dermatitis (AD) and rhinitis are common atopic diseases that may co-occur owing to an overlap in pathophysiology. Although most cases of both diseases are mild and managed with topical anti-inflammatory medicaments, the advent of new systemic and biologic treatments targeting type 2 inflammation in both diseases warrants further insight in the exact overlap of AD and rhinitis.
To determine the association between AD and rhinitis.
A systematic review and meta-analysis of the databases PubMed, Embase, and CNKI were performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Pooled prevalence and pooled odds ratios (ORs) with 95% confidence intervals (95% CIs) were calculated.
The search resulted in 10,422 citations, and 341 and 302 articles were included in the qualitative and quantitative analyses, respectively. The pooled prevalence of rhinitis was 40.5% (95% CI 39.0-42.0) in patients with AD and 18.0% (95% CI 16.7-19.2) in the reference individuals without AD. The pooled prevalence of having both rhinitis and asthma was 14.2% (95% CI 13.0-15.5) in patients with AD. There was an association between AD and rhinitis (OR 3.00, 95% CI 2.83-3.18), allergic rhinitis (OR 3.25, 95% CI 2.26-4.66), and nonallergic rhinitis (OR 1.99, 95% CI 1.39-2.86), respectively.
Rhinitis, both allergic and nonallergic forms, is very common in patients with AD. Future investigations should clarify how medications targeting both diseases should be indicated in these patients.
特应性皮炎(AD)和鼻炎是常见的特应性疾病,由于其病理生理学存在重叠,可能同时发生。虽然大多数这两种疾病的病例都比较轻微,通过局部抗炎药物进行治疗,但由于针对这两种疾病的 2 型炎症的新型全身和生物治疗的出现,需要进一步深入了解 AD 和鼻炎的确切重叠情况。
确定 AD 和鼻炎之间的关联。
根据系统评价和荟萃分析的首选报告项目,对 PubMed、Embase 和 CNKI 数据库进行了系统评价和荟萃分析。计算了合并患病率和合并优势比(OR)及其 95%置信区间(95%CI)。
搜索结果产生了 10422 条引文,分别有 341 篇和 302 篇文章纳入定性和定量分析。AD 患者的鼻炎合并患病率为 40.5%(95%CI 39.0-42.0),而无 AD 的参考个体的鼻炎合并患病率为 18.0%(95%CI 16.7-19.2)。AD 患者同时患有鼻炎和哮喘的合并患病率为 14.2%(95%CI 13.0-15.5)。AD 与鼻炎(OR 3.00,95%CI 2.83-3.18)、过敏性鼻炎(OR 3.25,95%CI 2.26-4.66)和非过敏性鼻炎(OR 1.99,95%CI 1.39-2.86)均存在关联。
鼻炎,包括过敏性和非过敏性,在 AD 患者中非常常见。未来的研究应阐明针对这两种疾病的药物在这些患者中的应用指征。